Martine Bayssas

Title: Martine Bayssas: Innovator in Pharmaceutical Solutions

Introduction

Martine Bayssas is a prominent inventor based in Lausanne, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug preparations. Her innovative work has led to the creation of a unique formulation that enhances the stability and usability of oxaliplatinum, a key chemotherapy drug.

Latest Patents

Martine Bayssas holds 1 patent for her invention titled "Pharmaceutically stable oxaliplatinum preparation for parenteral administration." This invention addresses the challenges associated with the stability of oxaliplatinum in solution. The preparation ensures that the oxaliplatinum remains in a precipitate-free, colorless, and clear solution, even after being preserved for a pharmaceutical acceptable duration. The formulation includes a solvent with a concentration of at least 7 mg/ml and incorporates hydroxylated derivatives such as 1,2-propanediol, glycerol, maltitol, saccharose, and inositol.

Career Highlights

Martine has established herself as a key figure in the pharmaceutical industry through her work at Debiopharm S.A. Her expertise in drug formulation and stability has been instrumental in advancing therapeutic options for patients.

Collaborations

Throughout her career, Martine has collaborated with notable colleagues, including Houssam Ibrahim and Henri Pourrat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Martine Bayssas is a trailblazer in the pharmaceutical field, with her innovative patent contributing to the advancement of drug stability and administration. Her work exemplifies the impact of dedicated inventors in improving healthcare solutions.